Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chidamide + R-GemOx in R/R DLBCL
NCT04022005Phase 2Completed
- Sponsor
- Sun Yat-sen University
- Start
- Jun 2019
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tucidinostat in diffuse large B-cell lymphoma (DLBCL), sponsored by Sun Yat-sen University. Started Jun 2019; status: completed.
02
Drugs
tucidinostat
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT04022005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04022005.